p53 gene mutation and ink4a-arf-deletion appear to be two mutually exclusive events in human glioblastoma

Oncogene

Volumn 19, Issue 33, 2000, Pages 3816-3822

  Fulci, Giulia ^a,b   Labuhn, Martin ^c   Maier, Daniel ^c   Lachat, Yan ^a   Hausmann, Oliver ^c   Hegi, Monika E ^a   Janzer, Robert C ^a   Merlo, Adrian ^c   Van Meir, Erwin G ^a,b  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Brain tumor; egfr; mdm2; p14arf; p16; Tumor suppressor

Indexed keywords

PROTEIN MDM2; PROTEIN P16; PROTEIN P53;

ARTICLE; CARCINOGENESIS; CHROMOSOME 10Q; CHROMOSOME 9P; CONTROLLED STUDY; GENE DELETION; GENE MAPPING; GENE MUTATION; GENE OVEREXPRESSION; GLIOBLASTOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0034601410     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1203700     Document Type: Article

References (48)

1. Biernat W, Kleihues P, Yonekawa Y and Ohgaki H. (1997a). Neuropathol. Exp. Neurol., 56, 180-185.
2. Biernat W, Tohma Y, Yonekawa Y, Kleihues P and Ohgaki H. (1997b). Acta. Neuropathol (Berl.), 94, 303-309.
3. Cairns P, Polascik TJ, Eby Y, Tokino K, Califano J, Merlo A, Mao L, Herath J, Jenkins R, Westra W et al. (1995). Nat. Genet., 11, 210-212.
4. Chiariello E, Roz L, Albarosa R, Magnani I and Finocchiaro G. (1998). Oncogene, 16, 541-545.
5. Costello JF, Plass C, Arap W, Chapman VM, Held WA, Berger MS, Huang HJS and Cavenee WK. (1997). Cancer Res., 57, 1250-1254.
6. de Stanchina E, McCurrach ME, Zindy F, Shieh SY, Ferbeyre G, Samuelson AV, Prives C, Roussel MF, Sherr CJ and Lowe SW. (1998). Genes Dev., 12, 2434-2442.
7. Duerr EM Rollbrocker B, Hayashi Y, Peters N, Meyer-Puttlitz B, Louis DN, Schramm J, Wiestler OD, Parsons R, Eng C and von Deimling A. (1998). Oncogene, 16, 2259-2264.
8. Duro D, Bernard O, Della Valle V, Berger R and Larsen CJ. (1995). Oncogene, 11, 21-29.
9. Frye RA, Benz CC and Liu E. (1989). Oncogene, 4, 1153-1157.
10. Fueyo J, Gomez-Manzano C, Yung WK and Kyritsis AP. (1998). Neurology, 51, 1250-1255.
11. Fulci G, Ishii N and Van Meir EG. (1998). Brain Pathol., 8, 599-613.
12. Gazzeri S, Della Valle V, Chaussade L, Brambilla C, Larsen CJ and Brambilla E. (1998). Cancer Res., 58, 3926-3931.
13. Grossman SR, Perez M, Kung AL, Joseph M, Mansur C, Xiao ZX, Kumar S, Howley PM and Livingston DM. (1998). Mol. Cell, 2, 405-415.
14. Hayashi Y, Ueki K, Waha A, Wiestler OD, Louis DN and von Deimling A. (1997). Brain Pathol., 7, 871-875.
15. He J, Allen JR, Collins VP, Allalunis-Turner MJ, Godbout R, Day RS, III and James CD. (1994). Cancer Res., 54, 5804-5807.
16. Hegi ME, zur Hausen A, Ruedi D, Malin G and Kleihues P. (1997). Int. J. Cancer, 73, 57-63.
17. Honda R and Yasuda H. (1999). EMBO J., 18, 22-27.
18. Hunter SB, Abbott K, Varma VA, Olson JJ, Barnett DW and James CD. (1995). J. Neuropathol. Exp. Neurol., 54, 57-64.
19. Ichimura K, Bolin MB, Goike HM, Schmidt EE, Moshref A and Collins VP. (2000). Cancer Res., 60, 417-424.
20. Jen J, Harper JW, Bigner SH, Bigner DD, Papadopoulos N, Markowitz S, Willson JK, Kinzler KW and Vogelstein B. (1994). Cancer Res., 54, 6353-6358.
21. Kamb A, Shattuck-Eidens D, Eeles R, Liu Q. Gruis NA, Ding W, Hussey C, Tran T, Miki Y, Weaver-Feldhaus J et al. (1994). Nat. Genet., 8, 23-26.
22. Kamijo T, Zindy F, Roussel MF, Quelle DE, Downing JR, Ashmun RA, Grosveld G and Sherr CJ. (1997). Cell, 91, 649-659.
23. Kleihues P, Ohgaki H, Eibl RH, Reichel MB, Mariani L, Gehring M, Petersen I, Holl T, von Deimling A, Wiestler OD, et al. (1994). Recent Results Cancer Res., 135, 25-31.
24. Landers JE, Haines DS, Strauss JF, III and George DL. (1994). Oncogene, 9, 2745-2750.
25. Maddalena AS, Hainfellner JA, Hegi ME, Glatzel M and Aguzzi A. (1999). Brain Pathol., 9, 627-637.
26. Maier D, Comparone D, Taylor E, Zhang Z, Gratzl O, Van Meir EG, Scott RJ and Merlo A. (1997). Oncogene, 15, 997-1000.
27. Maier D, Zhang Z, Taylor E, Hamou MF, Gratzl O, Van Meir EG, Scott RJ and Merlo A. (1998). Oncogene, 16, 3331-3335.
28. Mao L, Merlo A, Bedi G, Shapiro GI, Edwards CD, Rollins BJ and Sidransky D. (1995). Cancer Res., 55, 2995-2997.
29. Meyer-Puttlitz B, Hayashi Y, Waha A, Rollbrocker B, Bostrom J, Wiestler OD, Louis DN, Reifenberger G and von Deimling A. (1997). Am. J. Pathol., 151, 853-857.
30. Mollenhauer J, Wiemann S, Scheurlen W, Korn B, Hayashi Y, Wilgenbus KK, von Deimling A and Poustka A. (1997). Nat. Genet., 17, 32-39.
31. Nakamura H, Yoshida M, Tsuiki H, Ito K, Ueno M, Nakao M, Oka K, Tada M, Kochi M, Kuratsu J, Ushio Y and Saya H. (1998). Oncogene, 16, 1009-1019.
32. Nishikawa R, Furnari FB, Lin H, Arap W, Berger MS, Cavenee WK and Huang HJS. (1995). Cancer Res., 55, 1941-1945.
33. Nishikawa R, Ji XD, Harmon RC, Lazar CS, Gill GN, Cavenee WK and Huang HJS. (1994). Proc. Natl. Acad. Sci. USA, 91, 7727-7731.
34. Oliner JD, Pietenpol JA, Thiagalingam S, Gyuris J, Kinzler KW and Vogelstein B. (1993). Nature, 362, 857-860.
35. Pomerantz J, Schreiber-Agus N, Liegeois NJ, Silverman A, Alland L, Chin L, Potes J, Chen K, Orlow I, Lee HW, Cordon-Cardo C and DePinho RA. (1998). Cell, 92, 713-723.
36. Reifenberger G, Liu L, Iehimura K, Schmidt EE and Collins VP. (1993). Cancer Res., 53, 2736-2739.
37. Sanchez-Cespedes M, Reed AL, Buta M, Wu L, Westra WH, Herman JG, Yang SC, Jen J and Sidransky D. (1999). Oncogene, 18, 5843-5849.
38. Schmidt EE, Ichimura K, Reifenberger G and Collins VP. (1994). Cancer Res., 54, 6321-6324.
39. Stone S, Jiang P, Dayananth P, Tavtigian SV, Katcher H, Parry D, Peters G and Kamb A. (1995). Cancer Res., 55, 2988-2994.
40. Sure U, Ruedi D, Tachibana O, Yonekawa Y, Ohgaki H, Kleihues P and Hegi ME. (1997). J. Neuropathol. Exp. Neurol., 56, 782-789.
41. Teng DH, Hu R, Lin H, Davis T, Iliev D, Frye C, Swedlund B, Hansen KL, Vinson VL, Gumpper KL, Ellis L, El-Naggar A, Frazier M, Jasser S, Langford LA, Lee J, Mills GB, Pershouse MA, Pollack RE, Tornos C, Troncoso P, Yung WK, Fujii G, Berson A, Steck PA et al. (1997). Cancer Res., 57, 5221-5225.
42. von Deimling A, Louis DN and Wiestler OD. (1995). Glia, 15, 328-338.
43. Vonlanthen S, Heighway J, Tschan MP, Borner MM, Altermatt HJ, Kappeler A, Tobler A, Fey MF, Thatcher N, Yarbrough WG and Betticher DC. (1998). Oncogene, 17, 2779-2785.
44. Wang SI, Pue J, Li J, Bruce JN, Cairns P, Sidransky D and Parsons R. (1997). Cancer Res., 57, 4183-4186.
45. Waridel F, Estreicher A, Bron L, Flaman JM, Fontolliet C, Monnier P, Frebourg T and Iggo R. (1997). Oncogene, 14, 163-169.
46. Xiao ZX, Chen J, Levine AJ, Modjtahedi N, Xing J, Sellers WR and Livingston DM. (1995). Nature, 375, 694-698.
47. Zhang Y and Xiong Y. (1999). Mol. Cell, 3, 579-591.
48. Zindy F, Eischen CM, Randle DH, Kamijo T, Cleveland JL, Sherr CJ and Roussel MF. (1998). Genes Dev., 12, 2424-2433.